Toronto Dominion Bank Profound Medical Corp. Transaction History

Toronto Dominion Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.25 - $9.07 $601 - $752	-83 Reduced 66.94%	41 $0
Q1 2024 May 14, 2024	BUY	$7.3 - $9.46 $627 - $813	86 Added 226.32%	124 $1,000
Q4 2023 Feb 13, 2024	BUY	$7.85 - $11.18 $298 - $424	38 New	38 $0
Q2 2023 Feb 14, 2024	SELL	$9.27 - $14.88 $83 - $133	-9 Reduced 23.68%	29 $0
Q2 2023 Aug 10, 2023	SELL	$9.27 - $14.88 $769 - $1,235	-83 Reduced 74.11%	29 $0
Q1 2023 May 11, 2023	BUY	$8.85 - $13.27 $991 - $1,486	112 New	112 $1,000
Q2 2022 Aug 11, 2022	SELL	$6.34 - $9.53 $2,371 - $3,564	-374 Reduced 91.0%	37 $0
Q1 2022 May 09, 2022	BUY	$8.16 - $11.33 $3,272 - $4,543	401 Added 4010.0%	411 $4,000
Q4 2021 Feb 04, 2022	SELL	$10.38 - $15.2 $4,837 - $7,083	-466 Reduced 97.9%	10 $0
Q3 2021 Nov 08, 2021	BUY	$13.6 - $17.88 $3,726 - $4,899	274 Added 135.64%	476 $7,000
Q2 2021 Aug 13, 2021	BUY	$16.0 - $20.59 $3,232 - $4,159	202 New	202 $3,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.